{
  "actions": [
    {
      "acted_at": "2020-09-09",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2020-09-09",
      "action_code": "",
      "committees": [
        "SSBK"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s4542-116",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Banking, Housing, and Urban Affairs",
      "committee_id": "SSBK"
    }
  ],
  "congress": "116",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2020-09-09",
  "number": "4542",
  "official_title": "A bill to prohibit distribution abroad of COVID-19 vaccines developed with the support of Federal funding until the domestic need for the vaccine has been met.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "America First Vaccine Act",
  "sponsor": {
    "bioguide_id": "T000476",
    "district": null,
    "name": "Tillis, Thomas",
    "state": "NC",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2020-09-09",
  "subjects": [
    "Cardiovascular and respiratory health",
    "Emergency medical services and trauma care",
    "Health",
    "Health programs administration and funding",
    "Immunology and vaccination",
    "Infectious and parasitic diseases",
    "Manufacturing",
    "Trade restrictions"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2020-09-09",
    "date": "2020-10-21T19:24:00Z",
    "text": "America First Vaccine Act \n\nThis bill prohibits a U.S.-headquartered manufacturer of a COVID-19 (i.e., coronavirus disease 2019) vaccine that was developed with federal pandemic relief funding from distributing it outside of the United States, unless the Department of Health and Human Services (HHS) certifies that domestic need for the vaccine already has been met.\n\nHowever, HHS may waive the certification requirement and permit distribution outside of the United States if HHS makes a determination that such distribution would be in the interest of U.S. public health.\n\nA manufacturer that violates the requirement must reimburse the federal government for all amounts received by the manufacturer in support of development of the vaccine, plus interest."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "America First Vaccine Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "America First Vaccine Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to prohibit distribution abroad of COVID-19 vaccines developed with the support of Federal funding until the domestic need for the vaccine has been met.",
      "type": "official"
    }
  ],
  "updated_at": "2023-01-11T13:44:47Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/s/BILLSTATUS-116s4542.xml"
}